Skip to main content

AscellaHealth Ranks No. 46 on Inc. Magazine’s List of the Northeast Region’s Fastest-Growing Private Companies

Companies on the 2024 Inc. 5000 Regionals: Northeast list had an average growth rate of 155.84 percent.

Inc. magazine today revealed that AscellaHealth is No. 46 on its fourth annual Inc. 5000 Regionals: Northeast list, the most prestigious ranking of the fastest-growing Northeast private companies, based in Pennsylvania, New York, Vermont, New Hampshire, Maine, Massachusetts, Connecticut, Rhode Island, and New Jersey. Born of the annual Inc. 5000 franchise, this regional list represents a unique look at the most successful companies within the Northeast economy’s most dynamic segment–its independent small businesses.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240228838312/en/

(Graphic: Business Wire)

(Graphic: Business Wire)

“It is truly amazing for our growing team of industry experts to witness the incredible growth of AscellaHealth, and equally gratifying to have this confirmed for a fourth consecutive year as one of the most successful and fastest-growing companies in the region by Inc. 5000 Regionals: Northeast,” says Dea Belazi, CEO, AscellaHealth. “This distinction is testimony to not only our elevated market position, but also the strength of our innovative solutions which enable patients with complex and chronic conditions to access novel therapies and improve clinical outcomes. Our comprehensive service portfolio is designed to serve all industry stakeholders, from pharmaceutical and biotech manufacturers worldwide to addressing the unmet needs of payers and health plans for more control over medical and pharmacy spend and improved outcomes. AscellaHealth truly stands above its competitors with a customized and consultative approach that encompasses supporting commercialization of novel, expensive specialty medications and therapies, streamlining communications channels between providers, pharmacists and patients, enhancing patient access to medications and optimizing the prescription-treatment journey of rare disease and specialty patients.”

The companies on this list show a remarkable rate of growth across all industries in the Northeast region. Between 2020 and 2022, these 198 private companies had an average growth rate of 155.84 percent; by 2023, they’d also added 14,560 jobs and $15.7 billion to the region’s economy.

Complete results of the Inc. 5000 Regionals: Northeast, including company profiles, can be found at inc.com/Northeast starting February 27, 2024. You’ll also find an interactive database that can be sorted by industry, metro area, and other criteria.

“The honorees in our Inc. 5000 network are the Who’s Who of private companies. They’re energizing regional economies as they engineer the future of their industries. Learn who they are and what they do — they’ll be impacting things for a while,” said Eric Hagerman, Special Projects Editor at Inc. Media.

About AscellaHealth LLC

AscellaHealth, a global healthcare and specialty pharmacy solutions organization, serving patients, life sciences manufacturers, payers and providers, offers a comprehensive portfolio of uniquely tailored, tech-enabled services supporting complex, chronic conditions or rare diseases that require specialty medications and/or cell and gene therapies. A recipient of numerous industry awards for innovation, including Deloitte Technology Fast 500™ and Inc. 5000, AscellaHealth’s customized, patient-centric approach is built upon proprietary technology processes for end-to-end solutions to streamline the commercialization of specialty medications and proactively address unmet client needs, optimize clinical health outcomes and improve the quality of life for this patient population. AscellaHealth brings a rare and special perspective to all stakeholders. Visit www.AscellaHealth.com.

More about Inc. and the Inc. 5000 Regionals

Methodology

The 2024 Inc. 5000 Regionals are ranked according to percentage revenue growth when comparing 2020 and 2022. To qualify, companies must have been founded and generating revenue by March 31, 2020. They had to be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2022. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2020 is $100,000; the minimum for 2022 is $1 million. As always, Inc. reserves the right to decline applicants for subjective reasons.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers and the credibility that helps them drive sales and recruit talent.

The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit www.inc.com.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.